Abeona Therapeutics, Inc. (NASDAQ:ABEO) shares are trading higher on Wednesday on possible continued strength after the Food and Drug Administration (FDA) announced approval for its gene therapy.
What To Know: The FDA announced on Tuesday approval of ZEVASKYN, a gene therapy for the…